Archive for November, 2018

No Wi-Fi on Metro North, and here’s why | CT Viewpoints

Tuesday, November 6th, 2018

https://ctviewpoints.org/2016/03/31/no-wi-fi-on-metro-north-and-heres-why/

Upper East Café

Monday, November 5th, 2018

https://www.uecnyc.com/
62 & 3, opens at 8a

Cat’s in the Cradle – Wikipedia

Sunday, November 4th, 2018

https://en.wikipedia.org/wiki/Cat%27s_in_the_Cradle

Powering the internet of things | August 7, 2017 Issue – Vol. 95 Issue 32 | Chemical & Engineering News

Sunday, November 4th, 2018

Powering the internet of things
https://CEN.ACS.org/articles/95/i32/Powering-internet-things.html Great variety of sources & uses for #EnergyHarvesting devices — eg smart card readers for door & sensors for T gradients

QT:{{”
“Like Enerbee, many energy-harvesting firms remain optimistic and say the technology is improving. Most also acknowledge, as does Alta’s Vijh, that “the market for energy harvesting and the internet of things is a little slow now.” But sooner or later, he says, “it’s going to happen.””
“}}

Powering the internet of things | August 7, 2017 Issue – Vol. 95 Issue 32 | Chemical & Engineering News
https://cen.acs.org/articles/95/i32/Powering-internet-things.html

DNA Sequencing Giant Illumina Will Buy Pacific Biosciences For $1.2 Billion – Exclusive CEO Interview

Sunday, November 4th, 2018

We’re now all ILLUMINATED: DNA Sequencing Giant $ILMN Will Buy @PacBio For $1.2B, by @MatthewHerper
https://www.Forbes.com/sites/matthewherper/2018/11/01/dna-sequencing-giant-illumina-will-buy-pacific-biosciences-for-12-billion–exclusive-ceo-interview/ After raising $360M from VCs + $200M from an IPO

QT:{{”
“Pacific Biosciences was originally supposed to be an Illumina-killer. Founded in 2003 by chief technology officer, Steven Turner, who invented the firm’s basic technology with PacBio’s chief scientific officer, Jonas Korlach, PacBio emerged in 2009 boasting that it would disrupt the sequencing market, raising $360 million in venture capital and scoring a $200 million initial public offering. But its machines were too slow, expensive and unwieldy to slow down Illumina’s ascent. Shares plummeted, and even at the rich premium being offered by Illumina, shares are at half the IPO price.”
“}}

An Aging Marathoner Tries to Run Fast After 40 | WIRED

Saturday, November 3rd, 2018

https://www.wired.com/story/aging-marathoner-tries-to-run-fast-after-40/

Michael Specter: The Growing Battle Over How to Treat Lyme Disease : The New Yorker

Saturday, November 3rd, 2018

http://www.newyorker.com/reporting/2013/07/01/130701fa_fact_specter

QT:{{”
“The disease is caused by the bacterium Borrelia burgdorferi. In the Northeast and the Midwest, B. burgdorferi is transmitted by the bite of a black-legged tick, Ixodes scapularis. (In the Western United States, a related tick, Ixodes pacificus, prevails, and in Europe the main vector is Ixodes ricinus.) Lyme was all but unknown until 1977, when Allen Steere, a rheumatologist at Yale, produced the first definitive account of the infection. The condition was initially thought to have been an outbreak of juvenile rheumatoid arthritis in and around Lyme, Connecticut. In 1982, Willy Burgdorfer, a medical entomologist at the National Institutes of Health’s Rocky Mountain Laboratories, determined that the infection was caused by the previously unknown spirochete borrelia. As is common in scientific practice, the bacterium was named for him: Borrelia burgdorferi.”

“The controversy over Lyme disease is unlikely to diminish until scientists resolve at least two critical, but related, questions. Can the bacteria persist in the body, causing harm and illness months or even years after treatment has ended? And can prolonged antibiotic therapy destroy the remaining bacteria?”
“}}

How to Create a Strong Password That You Will Not Forget

Saturday, November 3rd, 2018

https://www.makeuseof.com/tag/create-strong-password-forget/

Dopamine receptor D2 – Wikipedia – DRD2

Saturday, November 3rd, 2018

https://en.wikipedia.org/wiki/Dopamine_receptor_D2

QT:{{”
Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2gene. After work from Paul Greengard’s lab had suggested that dopamine receptors were the site of action of antipsychotic drugs, several groups (including those of Solomon Snyder and Philip Seeman) used a radiolabeled antipsychotic drug to identify what is now known as the dopamine D2receptor.[5] The dopamine D2 receptor is the main receptor for most antipsychotic drugs. The structure of DRD2 in complex with the atypical antipsychotic risperidone has been determined.[6]
“}}

NMDA receptor – Wikipedia

Saturday, November 3rd, 2018

https://en.wikipedia.org/wiki/NMDA_receptor

QT:{{”
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel protein found in nerve cells. The NMDA receptor is one of three types of ionotropic glutamate receptors. The other receptors are the AMPA and kainate receptors. It is activated when glutamate and glycine (or D-serine) bind to it, and when activated it allows positively charged ions to flow through the cell membrane.[2] The NMDA receptor is very important for controlling synaptic plasticity and memory function.[3]
“}}